on:
NCPR is supported by:
 Hourly Newscast4 min., 45 sec.
|
Programs
Latest program rundownComing up:
Latest Features:
May 23, 2013 | NPR ·
May 23, 2013 | NPR ·
May 23, 2013 | NPR ·
Latest program rundownComing up:
Latest Features:
May 23, 2013 | NPR ·
May 23, 2013 | NPR ·
May 23, 2013 | NPR ·
Latest Saturday rundownWE Saturday Feature
May 18, 2013 | NPR ·
Latest Sunday rundown
WE Sunday Feature
May 19, 2013 | NPR ·
Alzheimer's disease
Apr 9, 2013 — Drug companies have developed several Alzheimer's drugs that seemed to work in mice but did not help people with the disease. So scientists inserted human genes into rats in hopes of getting a better model for testing the drugs.
Mar 19, 2013 — Deaths from the disease have increased by 68 percent between 2000 and 2010. One reason: We're living longer, and deaths from other causes, like heart disease and prostate cancer, are going down.
Jan 31, 2013 — A drug used in brain scans to help doctors detect clumps of protein associated with Alzheimer's disease was approved by the Food and Drug Administration last year. Now Medicare officials are weighing whether to cover it.
Comments |
Jan 10, 2013 — Neuroscientists have found that bilingual seniors were better at certain skills that can fade with age than their monolingual peers, which could help protect them against Alzheimer's disease. But the researchers don't know whether learning a second language in adulthood would provide the same benefit.
Comments |
Dec 26, 2012 — The year saw some disappointments in the development of drugs to treat Alzheimer's. But the setbacks were offset by progress in other areas. The upshot from this year's mixed results, some scientists say, is that treatment for Alzheimer's needs to start long before forgetfulness and muddled thinking are apparent.
Oct 17, 2012 — New research suggests that by the time an Alzheimer's patient is diagnosed, many key neurons are already dead. Neuroscientists say it's possible that several recent trials of drugs for Alzheimer's have failed because the drugs were given after symptoms had already started to appear.
Aug 24, 2012 — It's the latest setback in a field marked by failure. Earlier this month, Pfizer and Johnson & Johnson said they were dropping development of a similar experimental drug after big clinical studies showed it wasn't working.
Comments |
Aug 16, 2012 — Would you get tested for your potential risk for Alzheimer's disease, even though the prediction is imperfect and there is no cure for the condition? Studies suggest people can handle the results just find.
Comments |
Aug 7, 2012 — Pfizer's research on an experimental drug that attacks plaques in the brain has been discontinued. But scientists say they're hopeful that new treatments that attack a specific protein in plaques will have better success.
Comments |
Jul 11, 2012 — The mutation is rare but it appears to protect some people from developing the disease. The finding is an encouraging sign for drug researchers looking for medicines that have a similar effect in the brain.
